市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 混合的 | 看跌 |
| Health Information Services (全球的) | 混合的 | 看跌 | |
| 股票 | Aclarion, Inc. | 混合的 | 看涨 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| ACON | - | - | - | 0.240 |
| STRM | 23 M | - | - | 2.10 |
| ICCT | 8 M | - | - | 8.91 |
| MGRX | - | - | - | 0.310 |
| HCAT | - | - | - | 1.18 |
| ZCMD | - | - | - | 0.010 |
AIStockmoo 评分
| 价值 35% | -0.4 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | -0.4 |
| 时机 35% | -0.5 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -2.5 |
| 技术平均移动指标 参考 | 2.5 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 新闻情绪 参考 | NA |
| 市场环境 | ×1.07 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | +12.2% |
| 支柱一致性 | ×1.00 |
| 不计入评分 | |
| 价格波动 参考 | 1.1 |
| 最终评分 | -0.34 |
|
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Value |
| 机构持股比例 | 0.08% |
该时间范围内无数据。
该时间范围内无数据。
投资组合